From the joint NHS pharmacy technical services groups, for distribution via local NHS network groups:- Supporting document for NPSA Injectables Patient Safety Alert
Attached is a document which may support work in your Trust as you undertake risk assessments in response to the NPSA's Promoting Safer Use of Injectable Medicines. The document gives example risk assessments for 100 of the more commonly-used drugs in adults - it is hoped that using the tool may allow you to focus on the more specific situations in your Trust, and on the task of reducing the ward-based risk identified.
Practices will vary between Trusts, so it is anticipated that the examples will be reviewed when applying them locally, particularly in atypical circumstances and in paediatrics.
The document has been provided in open-form, to allow you to copy or amend as needed. Document control is therefore the responsibility of the user.
The full NPSA patient safety alert, including pro-forma risk assessmenttools and supporting documentation may be found at:-. Note that action and response is required by 7th July 2007.
We hope these examples will be valuable in your work. Peter Rhodes - Chair, NHS Pharmaceutical Aseptic Services Group Bruce McElroy - Chair, NHS Pharmaceutical Production Committee Richard Bateman - Chair, NHS Pharmaceutical Quality Assurance Committee Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 1 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of risk assessments of injectable medicine products prepared in clinical areas Prepared Injectable Medicine Strength
High risk baseline. Assess local practice for all these groups. Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 2 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 3 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 4 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 5 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 6 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 7 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 8 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes Examples of Risk Assessments for Injectable Medicines Prepared in Clinical Areas - Compiled using the NPSA Risk Assessment Tool For Injectable Medicines, March 2007 Page 9 of 9 Source: Joint NHS pharmacy technical services groups (Aseptic Services Group, Production Committee, QA Committee), May 2007 Data is subject to change by users - Last saved by Peter Rhodes
Information sur les antiplaquettaires de 3ème génération De nombreux patients que vous prenez en charge sont traités par des agents antiplaquettaires du fait de problèmes cardiovasculaires. La recherche d’un traitement par l’une de ces molécules est indispensable dans le cadre de la prévention et de la prise en charge du risque hémorragique péri opératoire. Orthorisq sou